Clear Filters How Big Data and Computation Drive Allosteric Target Discovery March 6, 2022 How Big Data and Computation Drive Allosteric Target Discovery Read More Gain Therapeutics’ Small Molecule Approach for CNS diseases March 4, 2022 Gain Therapeutics’ Small Molecule Approach for CNS diseases Read More The Role of Allosteric Drug Discovery in Targeting Undruggable Proteins in Oncology March 2, 2022 The Role of Allosteric Drug Discovery in Targeting Undruggable Proteins in Oncology Read More AlphaFold has modeled a high percentage of unknown protein structures: Dr. Xavier Barril March 1, 2022 AlphaFold has modeled a high percentage of unknown protein structures: Dr. Xavier Barril Read More See-Tx applications for Protein Misfolding diseases February 27, 2022 See-Tx applications for Protein Misfolding diseases Read More Potential impact of Allosteric Drugs on Cancers, Neurodegenerative Diseases, and other serious diseases January 26, 2022 Potential impact of Allosteric Drugs on Cancers, Neurodegenerative Diseases, and other serious diseases Read More Alzheimer’s Disease – Everything you need to know about it January 21, 2022 Alzheimer’s Disease – Everything you need to know about it Read More The Role of Alpha-synuclein in Alzheimer’s Disease January 8, 2022 The Role of Alpha-synuclein in Alzheimer’s Disease Read More Leukodystrophy Therapy: How is Gain Therapeutics Developing First-in-class treatment for Krabbe Disease January 8, 2022 Leukodystrophy Therapy: How is Gain Therapeutics Developing First-in-class treatment for Krabbe Disease Read More Corporate Presentation August 2024 Corporate Presentation Download
